The Columbia-based company drove over 1,000% Revenue Growth since 2021, driven by actuarially validated outcomes, New and Expanded Strategic Partnerships, and Industry Recognition COLUMBIA, MARYLAND / ...

Alter Behavioral Health, a Pioneer in Transformative Mental Health Care, Celebrates the Grand Opening of Its Brand-New Residential Mental Health Facility in Irvine, California ...

SIOUX FALLS, SD / ACCESSWIRE / January 14, 2025 / Avel eCare, the nation's leading telemedicine provider of clinician-to-clinician services, proudly announces a strategic partnership with Cibolo ...

MURFREESBORO, TN / ACCESSWIRE / January 14, 2025 / It is with great sorrow that National Health Investors, Inc. (NYSE:NHI) acknowledges the loss of our long-time colleague and great friend, Joe Wakham ...

Terumo Blood and Cell Technologies (Terumo BCT), and FUJIFILM Irvine Scientific have announced a strategic collaboration to help accelerate T cell expansion using Fujifilm's PRIME-XV® T Cell Expansion ...

Pharmapack Europe & CPHI have outlined key trends for pharma in 2025, highlighting the return of funding liquidity—via increased VC investments and PE capital for M&A—alongside enhanced supply chain ...

Elsevier, a global leader in scientific information and analytics, announced today the appointment of Stuart Whayman as President of Corporate Markets effective January 6, 2025. Mr. Whayman will ...

Domino Printing Sciences (Domino) is pleased to announce the launch of its new Mx-Series electric pallet labeller – the Mx350i-eP. The new, electrically driven pallet labeller boasts a suite of smart ...

As the NHS faces another winter of unprecedented pressures, leading scientific organisations The Physiological Society and PHG Foundation, release a new report that proposes an innovative, data-driven ...

Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) is pleased to report on progress being made by Neurocrine Biosciences, Inc. (“Neurocrine”) regarding the clinical development of its ...

Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that the supplemental New Drug Application for ORPATHYS® (savolitinib) has been granted approval by the China National Medical Products ...

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumour DNA can predict lung cancer outcome in a Cancer Research UK-funded study.